Reportstack has announced a new market research publication on EpiCast Report: Major Depressive Disorder - Epidemiology Forecast to 2023. Major depressive disorder (MDD), also known as clinical depression or major depression, is widely recognized as one of the most common mental disorders in the world. MDD is a type of mood disorder characterized by persistent feelings of sadness, anger, loss, or frustration that can last from days to months and alternates with episodes of wellness. MDD is a highly debilitating condition that is associated with substantial morbidity and an enormous social and economic burden. The condition affects the thoughts, feelings, behavior, and physical health of an individual, leading to a range of psychological, physical, and social problems.
Epidemiologists forecast that the total prevalent cases of MDD in the 8MM will grow by 4.0% over the next decade, from 31,798,832 total prevalent cases in 2013 to 33,083,108 total prevalent cases in 2023. Epidemiologists attribute the growth in the total prevalent cases of MDD in the 8MM to changing population demographics in the respective markets, rather than to an actual increase in the prevalence of MDD in these markets.
Epidemiological forecast for the total prevalent cases of MDD in the 8MM is supported by epidemiologic data from country-specific studies that are nationally representative of the entire population in these markets. Epidemiological analysis included the most recently published nationally-representative studies in the 8MM that provided the total prevalence of MDD using the DSM-IV diagnostic criteria and the CIDI version 3.0, which facilitates for a meaningful comparison of the forecast total prevalent cases of MDD in the 8MM. Additionally, the use of the total prevalence to forecast the total prevalent cases of MDD in the 8MM further strengthens epidemiological analysis, because the total prevalence reflects the true burden of a highly undiagnosed disease like MDD.
Scope
The Major Depressive Disorder (MDD) EpiCast Report and EpiCast Model provide an overview of the risk factors and the global and historical trends of MDD in the 8MM (US, France, Germany, Italy, Spain, UK, Japan, and Australia). It includes a 10-year epidemiological forecast for the total prevalent cases of MDD segmented by age (20 years and older) and sex.
The MDD epidemiology report and model were written and developed by Masters- and PhD-level epidemiologists.
The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.
The EpiCast Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.
Reasons To Buy
Develop business strategies by understanding the trends shaping and driving the global MDD market.
Quantify patient populations in the global MDD market to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for MDD therapeutics in each of the markets covered.
Epidemiologists forecast that the total prevalent cases of MDD in the 8MM will grow by 4.0% over the next decade, from 31,798,832 total prevalent cases in 2013 to 33,083,108 total prevalent cases in 2023. Epidemiologists attribute the growth in the total prevalent cases of MDD in the 8MM to changing population demographics in the respective markets, rather than to an actual increase in the prevalence of MDD in these markets.
Epidemiological forecast for the total prevalent cases of MDD in the 8MM is supported by epidemiologic data from country-specific studies that are nationally representative of the entire population in these markets. Epidemiological analysis included the most recently published nationally-representative studies in the 8MM that provided the total prevalence of MDD using the DSM-IV diagnostic criteria and the CIDI version 3.0, which facilitates for a meaningful comparison of the forecast total prevalent cases of MDD in the 8MM. Additionally, the use of the total prevalence to forecast the total prevalent cases of MDD in the 8MM further strengthens epidemiological analysis, because the total prevalence reflects the true burden of a highly undiagnosed disease like MDD.
Scope
The Major Depressive Disorder (MDD) EpiCast Report and EpiCast Model provide an overview of the risk factors and the global and historical trends of MDD in the 8MM (US, France, Germany, Italy, Spain, UK, Japan, and Australia). It includes a 10-year epidemiological forecast for the total prevalent cases of MDD segmented by age (20 years and older) and sex.
The MDD epidemiology report and model were written and developed by Masters- and PhD-level epidemiologists.
The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.
The EpiCast Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.
Reasons To Buy
Develop business strategies by understanding the trends shaping and driving the global MDD market.
Quantify patient populations in the global MDD market to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for MDD therapeutics in each of the markets covered.
To view the table of contents and know more details please visit EpiCast Report: Major Depressive Disorder - Epidemiology Forecast to 2023.
No comments:
Post a Comment